633 related articles for article (PubMed ID: 23873873)
1. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
[TBL] [Abstract][Full Text] [Related]
3. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
5. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
[TBL] [Abstract][Full Text] [Related]
6. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
[TBL] [Abstract][Full Text] [Related]
7. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
8. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
[TBL] [Abstract][Full Text] [Related]
9. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
[TBL] [Abstract][Full Text] [Related]
10. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
11. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
12. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
[TBL] [Abstract][Full Text] [Related]
13. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
15. Laboratory evaluation of pheochromocytoma and paraganglioma.
Eisenhofer G; Peitzsch M
Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
[TBL] [Abstract][Full Text] [Related]
16. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites.
Peitzsch M; Pelzel D; Glöckner S; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Eisenhofer G
Clin Chim Acta; 2013 Mar; 418():50-8. PubMed ID: 23313054
[TBL] [Abstract][Full Text] [Related]
18. A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency.
Jian M; Huang H; Li K; Chuan L; Li L; Jiang L
Clin Biochem; 2021 Jan; 87():67-73. PubMed ID: 33096053
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
20. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
